Breo

Marketing

GSK earns FDA nod for triple-drug Trelegy Ellipta in asthma

The FDA approved Trelegy Ellipta as a maintenance therapy for asthma, making it the first once-daily inhaler of its kind approved for those patients.
Kyle Blankenship Sep 9, 2020 7:04pm

Glaxo wins much-needed FDA nod for blockbuster prospect Trelegy

Sep 19, 2017 9:33am

Xeljanz, Taltz and Breo notch highest TV ad view rates in July

Aug 9, 2017 9:35am

GSK's Breo aims for a real-world data boost

May 9, 2017 10:56am

Pfizer runs away with pharma brand ad-spending crown

Mar 13, 2017 5:21am

Trial flop scuttles Vectura's hopes for Flutiform in COPD

Aug 30, 2016 5:57pm